ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

ACS Prostate Cancer Recommendations Move Forward

August 7, 1992

One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns

July 27, 1990

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

AACR Membership Up 14 Percent Per Year Since ‘88

June 8, 1990

Hawkins Calls For Joins Cancer Center-Community Effort To Develop Better Technology Transfers

May 29, 1981